Van Anh Nguyen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Angiotensin Converting Enzyme

Top Venues

Therapeutic advances in hematology

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nina Frischhut, Van Anh Nguyen
A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab. Therapeutic advances in hematology 15 (2024)
Nina Frischhut, Van Anh Nguyen
A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab. Therapeutic advances in hematology 15 (2024)
Irina Robinson, Maximilian Johannes Hochmair, Manuela Schmidinger, Gudrun Absenger, Martin Pichler, Van Anh Nguyen, Erika Richtig, Barbara Margaretha Rainer, Leyla Ay, Christian Jansen, Cátia Pacífico, Alexander Knabl, Barbara Sladek, Nikolaus Gasche, Arschang Valipour
Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types. Cancers 15 (13) (2023)
Helena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, Daniel Pölöske, Andrea R Teufelberger, Elvin Dominic de Araujo, Abootaleb Sedighi, Ricarda Graf, Benjamin Spiegl, Isaac Lazzeri, Till Braun, Ines Garces de Los Fayos Alonso, Michaela Schlederer, Gerald Timelthaler, Petra Kodajova, Christine Pirker, Marta Surbek, Michael Machtinger, Thomas Graier, Isabella Perchthaler, Yi Pan, Regina Fink-Puches, Lorenzo Cerroni, Jennifer Ober, Moritz Otte, Jana D Albrecht, Gary Tin, Ayah Abdeldayem, Pimyupa Manaswiyoungkul, Olasunkanmi O Olaoye, Martin L Metzelder, Anna Orlova, Walter Berger, Marion Wobser, Jan P Nicolay, Fiona André, Van Anh Nguyen, Heidi A Neubauer, Roman Fleck, Olaf Merkel, Marco Herling, Ellen Heitzer, Patrick Thomas Gunning, Lukas Kenner, Richard H Moriggl, Peter Wolf
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma. EMBO molecular medicine 14 (12) (2022)